Evidence map›Paper›PMID 30446701›Full record

ArticleScientific reports2018

Unique, Intersecting, and Overlapping Roles of C/EBP β and CREB in Cells of the Innate Immune System.

Jason L Larabee, Garrett Hauck, Jimmy D Ballard

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. CCAAT/Enhancer-Binding ProteinJournal of diabetes research · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jason L LarabeeDepartment of Microbiology and Immunology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73190, USA.ORCID http://orcid.org/0000-0001-5757-7247
Garrett HauckDepartment of Microbiology and Immunology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73190, USA.
Jimmy D BallardDepartment of Microbiology and Immunology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73190, USA. jimmy-ballard@ouhsc.edu.
University of Oklahoma Health Sciences Center · US

Funding

Translation of immunologic technologies from basic research into pre-clinical nonU19AI062629 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI FARRIS, A DARISE · 2004 to 2023
$56.2M
NIAID NIH HHS U19 AI062629
6 · The paper itself

Abstract

CREB and C/EBP β signaling pathways are modulated during inflammation and also targeted by Bacillus anthracis edema toxin (ET), but how these factors individually and jointly contribute to changes in immune cell function is poorly understood. Using CRISPR/Cas9 gene editing, macrophage cell lines lacking CREB and isoforms of C/EBP β were generated and analyzed for changes in responses to LPS, ET, and IL-4. Macrophages lacking C/EBP β suppressed induction of IL-10 and Arg1, while IL-6 was increased in these cells following exposure to LPS. Examination of C/EBP β isoforms indicated the 38 kDa isoform was necessary for the expression of IL-10 and Arg1. ChIP-Seq analysis of CREB and C/EBP β binding to targets on the chromosome of human PBMC identified several regions where both factors overlapped in their binding, suggesting similar gene targeting or cooperative effects. Based on the ChIP-Seq data, a panel of previously unknown targets of CREB and C/EBP β was identified and includes genes such as VNN2, GINS4, CTNNBL1, and SULF2. Isoforms of a transcriptional corepressor, transducin-like enhancer of Split (TLE), were also found to have CREB and C/EBP β binding their promoter and were up regulated by ET. Finally, we explore a possible layer of C/EBP β regulation by a protein complex consisting of adenomatous polyposis coli (APC) and PKA. Collectively, these data provide new insights into the role of CREB and C/EBP β as immunosignaling regulators and targets of an important bacterial virulence factor.

Indexed as

Immunity, InnateAnimalsCCAAT-Enhancer-Binding Protein-betaCell LineCyclic AMPCyclic AMP Response Element-Binding ProteinCytokinesGene Expression RegulationHumansImmunomodulationInflammation MediatorsLeukocytesLeukocytes, MononuclearMacrophagesMiceRAW 264.7 CellsCCAAT-Enhancer-Binding Protein-betaCyclic AMPCyclic AMP Response Element-Binding ProteinCytokinesInflammation Mediators

Identifiers

PMID30446701
PMCPMC6240029
OpenAlexW2901417050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.